Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

Lidophil - Philippines FDA Drug Approval Details

Approvals/Philippines FDA/Lidophil

Approved

STANDARD

Lidophil

Hebei Tiancheng Pharmaceutical Co., Ltd.🇵🇭 Food and Drug Administration - Philippines

Approval Date: Jul 14, 2025
Approval ID: d2f8f8cee4c431a5
Company: Hebei Tiancheng Pharmaceutical Co., Ltd.
Type: Standard

Approval Details

Approval Id: d2f8f8cee4c431a5
Drug Approval Philippines Name: Lidophil
Product Name: Lidophil
Registration Number: DRP-12934
Brand Name: Lidophil
Generic Name: Lidocaine Hydrochloride
Dosage Form: Solution For Injection (IV)
Dosage Strength: 20 mg/mL (2% w/v)
Manufacturer: Hebei Tiancheng Pharmaceutical Co., Ltd.
Importer: PhilRx Pharma Inc.
Distributor: PhilRx Pharma Inc.
Issuance Date: 24 January 2023
Expiry Date: 04 November 2027
Pharmacologic Category: Local Anaesthetic
Classification: Prescription Drug (RX)

Active Ingredients

Approved

Quick Info

Agency

Philippines FDA

Country

🇵🇭

Approval Date

Jul 14, 2025

Approval ID

d2f8f8cee4c431a5

Type

Standard

Back to Philippines FDA Approvals